Successful treatment of an end-stage kidney disease patient presenting with severe Covid-19 disease using enhanced cytokine removal with haemoadsorption therapy in addition to standard management

Abstract

Endstage renal disease patients with severe COVID-19 disease has higher mortality rate as compared to those with no comorbidities. Here we report a case of endstage renal disease patient who was on regular haemodialysis presenting with severe COVID-19 disease and progressed to cytokine storm. In addition to standard management with steroids in view of the hypoxia, this patient received haemoadsorption therapy to aid cytokine removal hence potentially limiting the progression of the acute respiratory distress syndrome and preventing mortality. There are limited data on the use of haemoadsorption in endstage renal disease patients with COVID-19 disease. This patient survived to discharge without the need for supplemental oxygen. In conclusion, combined therapeutic modalities are possible promising treatment for severe COVID-19 infection in endstage renal disease patients.